Cited 17 time in
Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Young Ho | - |
| dc.contributor.author | Bae, Sang-Cheol | - |
| dc.contributor.author | Song, Gwan Gyu | - |
| dc.date.accessioned | 2021-08-02T18:26:29Z | - |
| dc.date.available | 2021-08-02T18:26:29Z | - |
| dc.date.issued | 2015-03 | - |
| dc.identifier.issn | 0198-8859 | - |
| dc.identifier.issn | 1879-1166 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/25629 | - |
| dc.description.abstract | Objective We explored whether cytotoxic T lymphocyte antigen-4 (CTLA-4) rs5742909, CD226 rs763361, FAS rs1800682, and FASL rs763110 polymorphisms are associated with rheumatoid arthritis (RA). Methods We performed a meta-analysis on the association between the four gene polymorphisms and RA. Results Nineteen studies were included in the meta-analysis. Meta-analysis of all study subjects showed no association between RA and the CTLA-4 rs5742909 T allele (OR = 1.057, 95% CI = 0.782–1.429, p = 0.719). However, the meta-analysis revealed an association between RA and the CD226 rs763361 T allele in all study subjects (OR = 1.294, 95% CI = 1.063–1.576, p = 0.010), and an association was found between the CD226 rs763361 TT genotype and RA in Asians (OR = 1.363, 95% CI = 1.126–1.651, p = 0.001). Meta-analysis showed no association between RA and the FAS rs1800682 G/A polymorphism. However, meta-analysis revealed an association between RA and the FASL rs763110 T allele in all study subjects (OR = 1.366, 95% CI = 1.093–1.707, p = 0.006) and in Asians (OR = 1.402, 95% CI = 1.059–1.855, p = 0.014). Conclusions Our meta-analysis demonstrates that the CD226 rs763361 and FASL rs763110 polymorphisms are associated with RA, especially in Asians. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.humimm.2015.01.023 | - |
| dc.identifier.scopusid | 2-s2.0-84924043054 | - |
| dc.identifier.wosid | 000350530800003 | - |
| dc.identifier.bibliographicCitation | Human Immunology, v.76, no.2-3, pp 83 - 89 | - |
| dc.citation.title | Human Immunology | - |
| dc.citation.volume | 76 | - |
| dc.citation.number | 2-3 | - |
| dc.citation.startPage | 83 | - |
| dc.citation.endPage | 89 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Immunology | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.subject.keywordPlus | SYSTEMIC-LUPUS-ERYTHEMATOSUS | - |
| dc.subject.keywordPlus | PROMOTER POLYMORPHISM | - |
| dc.subject.keywordPlus | AUTOIMMUNE-DISEASES | - |
| dc.subject.keywordPlus | GENE POLYMORPHISM | - |
| dc.subject.keywordPlus | EXON-1 REGIONS | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | POPULATION | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | PROTEIN | - |
| dc.subject.keywordPlus | HAPLOTYPES | - |
| dc.subject.keywordAuthor | Rheumatoid arthritis | - |
| dc.subject.keywordAuthor | CTLA-4 | - |
| dc.subject.keywordAuthor | CD226 | - |
| dc.subject.keywordAuthor | FAS | - |
| dc.subject.keywordAuthor | Polymorphism | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0198885915000245?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
